Hugh C. Rayner

TL;DR: Variability in demographic and comorbid conditions (as identified by dialysis facilities) explains only part of the differences in mortality between dialysis centers, both for comparisons made across continents and within the US.

TL;DR: There are differences in HCV prevalence and rate of seroconversion at the country and the hemodialysis facility level and the observed variation suggests opportunities for improved HCV outcomes.

TL;DR: Nonadherence was associated with increased mortality risk (skipping treatment, excessive IDWG, and high phosphate) and with hospitalization risk (kipping, high phosphate).

TL;DR: In this paper, the relationship between vascular access practice and outcomes was analyzed using an instrumental variable approach to decrease the treatment-by-indication bias of prior patient-level analyses.

TL;DR: Hospitalization risk was significantly higher in France than in other Euro-DOPPS countries and was significantly associated with prior peritoneal dialysis therapy, peripheral vascular disease, gastrointestinal bleeding in the prior year, diabetes, cancer, cardiac disease, psychiatric disease and recent onset of ESRD.